Synergizing radiotherapy and immunotherapy for locally advanced gastric cancer: evolving paradigms and future directions.
Saved in:
| Title: | Synergizing radiotherapy and immunotherapy for locally advanced gastric cancer: evolving paradigms and future directions. |
|---|---|
| Authors: | Lin S; Department of Radiation Oncology, Shenzhen Nanshan People's Hospital, Shenzhen, China., Pu W; Department of Radiation Oncology, Shenzhen Nanshan People's Hospital, Shenzhen, China.; Department of Radiation Oncology and Shenzhen Proton Therapy Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.; Medical Department of Shenzhen University/General Hospital of Shenzhen University/Academy of Clinical Medicine of Shenzhen University, Shenzhen, China., Su X; Department of Radiation Oncology and Shenzhen Proton Therapy Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China., Lei J; Department of Radiation Oncology and Shenzhen Proton Therapy Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China., Li J; Department of Radiation Oncology, Shenzhen Nanshan People's Hospital, Shenzhen, China., Chen C; Department of Radiation Oncology, Shenzhen Nanshan People's Hospital, Shenzhen, China., Xu J; Department of Radiation Oncology, South China Hospital, Medical School, Shenzhen University, Shenzhen, China., Xiao Q; Department of Radiation Oncology and Shenzhen Proton Therapy Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China., Zhang Z; Department of Radiation Oncology, Shenzhen Nanshan People's Hospital, Shenzhen, China.; Medical Department of Shenzhen University/General Hospital of Shenzhen University/Academy of Clinical Medicine of Shenzhen University, Shenzhen, China., Jin J; Department of Radiation Oncology and Shenzhen Proton Therapy Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.; State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 26; Vol. 17, pp. 1875451. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1875451 |
